FDA 510(k)
FDA class 2
Substantially Equivalent
🇺🇸 United States
QMS LIDOCAINE CALIBRATORS, MODEL 0374678
K Number: K091617
·
Decision Jul 17, 2009
Classifications
1
FEI Numbers
40
Registration Numbers
40
Same Product Code
122
Applicant Total
64
Review Days
44
Research this 510(k) in seconds
The Research Assistant summarizes clearance history, predicates and product-code trends — and cites every record.
Free to try · every answer cites its records
Basic Information
- Device Name
- QMS LIDOCAINE CALIBRATORS, MODEL 0374678
- K Number
- K091617
- Device Class
- FDA class 2
- Clearance Type
- Traditional
- Regulation Number
- 862.3200
- Medical Specialty
- Clinical Toxicology
- Decision
- Substantially Equivalent
- Statement or Summary
- Summary
- Applicant
- Thermo Fisher Scientific
- Date Received
- June 3, 2009
- Decision Date
- July 17, 2009
- Product Code
- DLJ
- Advisory Committee
- Clinical Toxicology
- Review Advisory Committee
- TX
- Third Party
- N
Classifications
This FDA 510(k) entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| DLJ | Calibrators, Drug Specific | FDA class 2 | Clinical Toxicology |
Similar 510(k) Clearances
Other 510(k) clearances with the same product code (DLJ), ordered by most recent decision date.
BENZODIAZEPINE CALIBRATOR SET, BENZODIAZEPINE CONTROL LEVEL 1, AND BENZODIAZEPINE CONTROL LEVEL 2
FDA 510(k)
FDA Class 2
·Clinical Toxicology
DIMENSION VISTA CSAE CALIBRATOR, MODEL KC440
FDA 510(k)
FDA Class 2
·Clinical Toxicology
DIMENSION VISTA SYSTEM ECSTASY CALIBRATOR, MODEL KC520
FDA 510(k)
FDA Class 2
·Clinical Toxicology
DIMENSION VISTA SYSTEM DRUG 3 CALIBRATOR (DRUG 3 CAL - KC430)
FDA 510(k)
FDA Class 2
·Clinical Toxicology
DIMENSION CYCLOSPORINE EXTENDED RANGE CALIBRATOR (DC108A)
FDA 510(k)
FDA Class 2
·Clinical Toxicology
DIMENSION TACR CALIBRATOR, MODEL DC107
FDA 510(k)
FDA Class 2
·Clinical Toxicology
Other Clearances by Thermo Fisher Scientific
| K Number | Device Name | ||
|---|---|---|---|
| K252062 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mL | Sep 25, 2025 | Substantially Equivalent |
| K250575 | The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mL | Sep 5, 2025 | Substantially Equivalent |
| K252014 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mL | Aug 28, 2025 | Substantially Equivalent |
| K250990 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mL | Jun 30, 2025 | Substantially Equivalent |
| K242843 | The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range of 0.008-16 ug/mL. | Jun 20, 2025 | Substantially Equivalent |
| K242659 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Vancomycin in the dilution range of 0.25-128 ug/mL | May 22, 2025 | Substantially Equivalent |
| K242658 | The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mL | Apr 15, 2025 | Substantially Equivalent |
| K243738 | The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mL | Feb 27, 2025 | Substantially Equivalent |
| K243201 | The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with penicillin in the dilution range of 0.015-32 ug/mL | Feb 10, 2025 | Substantially Equivalent |
| K242905 | The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of 0.12-32 ug/mL | Feb 10, 2025 | Substantially Equivalent |